Why Pregnancy Can Still Occur After Taking Birth Control

Despite widespread use and high efficacy when taken correctly, oral contraceptives are not 100% effective—and unintended pregnancies can occur even among consistent users. Understanding the reasons behind contraceptive failure is essential for informed decision-making and optimizing reproductive health.

One of the most common causes of breakthrough pregnancy is inconsistent or incorrect use. Combined oral contraceptives (COCs) require daily intake at approximately the same time each day; missing a pill—especially during the first or last week of the active pill pack—can significantly reduce hormone levels below the threshold needed to suppress ovulation, thicken cervical mucus, or alter endometrial receptivity. Progestin-only pills (POPs), which rely more heavily on cervical mucus thickening and endometrial changes, have an even narrower window: a delay of more than three hours (or 12 hours for some newer formulations) may compromise effectiveness.

Drug interactions represent another clinically significant factor. Enzyme-inducing medications—including certain antiepileptics (e.g., carbamazepine, phenytoin, rifampin), some antiretrovirals, and St. John’s wort—accelerate hepatic metabolism of steroid hormones, lowering circulating estrogen and progestin concentrations. This pharmacokinetic interference can render standard-dose pills subtherapeutic, increasing the risk of ovulation and conception.

Gastrointestinal disturbances also play a role. Severe vomiting within two hours of pill ingestion or prolonged diarrhea may prevent adequate absorption of active ingredients. In such cases, backup contraception (e.g., condoms) is recommended for at least seven days after symptoms resolve—or until hormonal levels are re-established.

Individual biological variability contributes as well. Factors such as higher body weight or obesity may influence drug distribution and clearance, though evidence remains mixed and does not universally support dose adjustment. Additionally, rare genetic polymorphisms affecting cytochrome P450 enzymes or sex hormone-binding globulin (SHBG) levels could theoretically alter hormonal bioavailability—but these are not routinely assessed in clinical practice.

Finally, user-related factors—including misinterpretation of instructions, confusion about placebo weeks, or initiating pills outside the recommended window (e.g., not starting on day 1 of menses or within five days of onset)—can undermine protection from the outset. Counseling on correct initiation, missed-pill protocols, and timely follow-up is therefore a critical component of contraceptive care.

In summary, while modern oral contraceptives offer highly reliable pregnancy prevention when used perfectly, real-world effectiveness hinges on adherence, awareness of interacting agents, and individual physiological considerations. Shared decision-making between clinicians and patients—centered on lifestyle, comorbidities, and medication regimens—remains key to selecting and sustaining the safest, most appropriate method.